It has also been used with good outcomes in treating many retinopathies with VEGF up-regulation, including AMD [16,17], diabetic retinopathy [18,19,20], vitreous hemorrhage [21,22], neovascular glaucoma [23], pathological myopia [24] and retinal vascular occlusion [25,26,27]. The gene discussed is VEGFA; the disease is retinal disorder.